TrialBMC cancer2014

Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.

Christel C L M Boons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.